Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
racemetyrosine
|
| gptkbp:CASNumber |
104404-17-3
|
| gptkbp:chemicalClass |
tyrosine derivative
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:Tyme_Technologies
|
| https://www.w3.org/2000/01/rdf-schema#label |
SM-88
|
| gptkbp:intendedUse |
gptkb:cancer
|
| gptkbp:mechanismOfAction |
metabolic therapy
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:studiedBy |
gptkb:rhabdomyosarcoma
pancreatic cancer prostate cancer |
| gptkbp:bfsParent |
gptkb:Tyme_Technologies
|
| gptkbp:bfsLayer |
7
|